title: Family attitudes and patient social adjustment in a longitudinal study of outpatient schizophrenics receiving low-dose neuroleptics: the family's view.
abstract: Adverse effects of neuroleptic medication have led to the attempt to develop alternative strategies for the treatment of schizophrenia, but it is generally conceded that these strategies may have their own negative outcomes in the form of symptom exacerbation, reduced social performance and worsened family interactions. This paper examines the effect of one such strategy, low doses of medication, on the social adjustment of and family response to chronic schizophrenic outpatients. Patients who were randomly assigned to either a low-dose or standard-dose condition were rated by their families on various aspects of social adjustment. Despite a considerably higher relapse rate in the low-dose condition, families reported patients in the low-dose condition to be no poorer in their social adjustment than standard-dose patients. In addition, families of low-dose patients were more satisfied with their patients' overall level of adjustment and were no more rejecting at endpoint than families of standard-dose patients. Low-dose patients were viewed even more favorably when patients who relapsed were excluded from the analysis. Negative family attitudes, particularly rejection, measured at study entry, were found to predict time to relapse in the low-dose group. Implications for treatment and family intervention are discussed.
authors: New York State Psychiatric Institute, Columbia University, NY 10032.
authors: D
authors: D
authors: Kreisman
authors: R
authors: R
authors: Blumenthal
authors: M
authors: M
authors: Borenstein
authors: M
authors: M
authors: Woerner
authors: J
authors: J
authors: Kane
authors: A
authors: A
authors: Rifkin
authors: G
authors: G
authors: Reardon
mesh_terms: D000293:Adolescent; D000328:Adult; D001290:Attitude; D004305:Dose-Response Relationship, Drug; D005190:Family; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012059:Rejection, Psychology; D012559:Schizophrenia / Q000188:drug therapy*; D012917:Social Adjustment
chemical_list: C011825:fluphenazine depot; D005476:Fluphenazine